Abstract:Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas-associated systems have recently emerged as a focal point for developing next-generation molecular diagnosis, particularly for nucleic acid detection. However, the detection of proteins is equally critical across diverse applications in biology, medicine, and the food industry, especially for diagnosing and prognosing diseases like cancer, Alzheimer and cardiovascular conditions. Despite recent efforts to adapt CRISPR/Cas systems for protein detection with immunoassays, these methods typically achieved sensitivity only in the femtomolar to picomolar range, underscoring the need for enhanced detection capabilities. To address this, we developed CRISPR-AMPED, an innovative CRISPR/Cas-based immunoassay enhanced by magnetic proximity extension and detection. This approach combines proximity extension assay (PEA) with magnetic beads that converts protein into DNA barcodes for quantification with effective washing steps to minimize non-specific binding and hybridization, therefore reducing background noise and increasing detection sensitivity. The resulting DNA barcodes are then detected through isothermal nucleic acid amplification testing (NAAT) using recombinase polymerase amplification (RPA) coupled with the CRISPR/Cas12a system, replacing the traditional PCR. This integration eliminates the need for thermocycling and bulky equipment, reduces amplification time, and provides simultaneous target and signal amplification, thereby significantly boosting detection sensitivity. CRISPR-AMPED achieves attomolar level sensitivity, surpassing ELISA by over three orders of magnitude and outperforming existing CRISPR/Cas-based detection systems. Additionally, our smartphone-based detection device demonstrates potential for point-of-care applications, and the digital format extends dynamic range and enhances quantitation precision. We believe CRISPR-AMPED represents a significant advancement in the field of protein detection.

Quantum-Dot-Encoded Beads-Enhanced CRISPR/Cas-Based Lateral-Flow Assay for the Amplification-Free, Sensitive, and Rapid Detection of Nucleic Acids in Breast Cancer

CRISPR/Cas12a Powered DNA Framework‐Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis

Asymmetric CRISPR enabling cascade signal amplification for nucleic acid detection by competitive crRNA

Advances in Amplification-Free Detection of Nucleic Acid: CRISPR/Cas System As a Powerful Tool.

High-fidelity CRISPR/Cas13a trans cleavage-driven assembly of single quantum dot nanosensor for ultrasensitive detection of long noncoding RNAs in clinical breast tissues

Enhancement of trans-cleavage activity of Cas12a with engineered crRNA enables amplified nucleic acid detection

Cas12aVDet: A CRISPR/Cas12a-Based Platform for Rapid and Visual Nucleic Acid Detection

Nucleic Acid Amplification-Free Biosensor for Sensitive and Specific Cfdna Detection Based on CRISPR-Cas12a and Single Nanoparticle Dark-Field Microscopy (DFM) Imaging

Enhanced CRISPR/Cas-Based Immunoassay through Magnetic Proximity Extension and Detection

Plasmonically Enhanced CRISPR/Cas13a‐Based Bioassay for Amplification‐Free Detection of Cancer‐Associated RNA

Ultrafast Visual Nucleic Acid Detection with CRISPR/Cas12a and Rapid PCR in Single Capillary

Double signal amplification strategy for ultrasensitive electrochemical biosensor based on nuclease and quantum dot-DNA nanocomposites in the detection of breast cancer 1 gene mutation.

CRISPR/Cas12a Bio-Assay Integrated with Metal-Organic Framework Based Enhanced Fluorescent Labels for Ultrasensitive Detection of Circulating Tumor DNA

Sensitive Detection of BRCA1 Gene Based on Target Proximity Induced Quenching of the Fluorescence of Copper Nanoclusters

Multiplex DNA sensor for BRAF and BRCA detection.

Dual-mode Colorimetric and Fluorescence Detection of BRCA1 Based on a CRISPR-Cas12a System

A Smart Fluorescent Biosensor for the Highly Sensitive Detection of BRCA1 Based on a 3D DNA Walker and ESDR Cascade Amplification

In Situ Hand-in-hand DNA Tile Assembly and CRISPR/Cas12a-based Ultrasensitive Detection for Leukemia Diagnosis

A Protospacer Adjacent Motif-Free, Multiplexed, and Quantitative Nucleic Acid Detection Platform with Barcode-Based Cas12a Activity

Cas12a/crRNA recognition initiated self-priming mediated chain extension for colorimetric Cell-free DNA (cfDNA) analysis

In Situ Hybridization Chain Reaction Mediated Ultrasensitive Enzyme-Free and Conjugation-Free Electrochemcial Genosensor for Brca-1 Gene in Complex Matrices